Speciality Medi, a company in the Pharmaceuticals industry, reported revenue of ₹87 crore and net profit of ₹9.00 crore for the September 2026 quarter.
Speciality Medi. (BSE: SPML) closed at ₹160.00 on 20 Nov 2026. Its market capitalisation is ₹141 crore and it trades at 8.2 times earnings.
Incorporated in 2021, Speciality Medicines Ltd is focused on the export, trading, and distribution of pharmaceutical medicines and vaccines.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.